Oxidative damage to RNA in neurodegenerative diseases.

Oxidative damage to RNA in neurodegenerative diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Oxidative damage to RNA in neurodegenerative diseases. Abstract Text:

Akihiko Nunomura,Kazuhiro Honda,Atsushi Takeda,Keisuke Hirai,Xiongwei Zhu,Mark A Smith,George Perry,

Since 1999, oxidative damage to RNA molecules has been described in several neurological diseases including Alzheimer's disease, Parkinson's disease, Down syndrome, dementia with Lewy bodies, prion disease, subacute sclerosing panencephalitis, and xeroderma pigmentosum. An early involvement of RNA oxidation of vulnerable neuronal population in the neurodegenerative diseases has been demonstrated, which is strongly supported by a recent observation of increased RNA oxidation in brains of subjects with mild cognitive impairment. Until recently, little is known about consequences and cellular handling of the RNA damage. However, increasing body of evidence suggests detrimental effects of the RNA damage in protein synthesis and the existence of several coping mechanisms including direct repair and avoiding the incorporation of the damaged ribonucleotides into translational machinery. Further investigations toward understanding of the consequences and cellular handling mechanisms of the oxidative RNA damage may provide significant insights into the pathogenesis and therapeutic strategies of the neurodegenerative diseases.

Oxidative damage to RNA in neurodegenerative diseases. Publishing Authors By Initials

A Nunomura,K Honda,A Takeda,K Hirai,X Zhu,MA Smith,G Perry,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Oxidative damage to RNA in neurodegenerative diseases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of biomedicine & biotechnology

VOLUME: 2006

Page Numbers: 82323

Journal Abbreviation: J. Biomed. Biotechnol.

ISSN: 1110-7243

DAY: 18

MONTH: 10

YEAR: 2006

Oxidative damage to RNA in neurodegenerative diseases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101135740

Oxidative damage to RNA in neurodegenerative diseases. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Oxidative damage to RNA in neurodegenerative diseases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Oxidative damage to RNA in neurodegenerative diseases.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biomed Biotechnol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Oxidative damage to RNA in neurodegenerative diseases Related Publications

• "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation.
• 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
• A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.
• Adults with autism show increased sensitivity to outcomes at low error rates during decision-making.
• Balanced production of ribosomal proteins.
• Bias, benefit, or both: evaluating new glioma therapies.
• Comparison of two methods for measuring tongue pressure during swallowing in people with head and neck cancer.
• Congenital glioblastoma: a clinicopathologic and genetic analysis.
• Constraints on practice.
• Gender identity and adjustment in black, Hispanic, and white preadolescents.
• Glioblastoma.
• Hierarchy of iron uptake systems: Yfu and Yiu are functional in Yersinia pestis.
• Identification of critical amino acid residues in the plague biofilm Hms proteins.
• Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.
• On-board Imaging - the Ipswich Experience.
• Oxidative damage to RNA in neurodegenerative diseases.
• Power in Numbers: Using EPINet Data to Promote Protective Policies for Healthcare Workers.
• Rasagiline: a review of its use in the management of Parkinson's disease.
• Rectus sheath hematoma: a series of unfortunate events.
• Road effects on abundance and fitness of Galápagos lava lizards (Microlophus albemarlensis).
• Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
• Selective reporting of pharmaceutical data leads major medical journals to change editorial policy.
• Small cell lung cancer: have we made any progress over the last 25 years?
• Spotlight on ramipril in the prevention of cardiovascular outcomes.
• Tacrolimus once-daily formulation : in the prophylaxis of transplant rejection in renal or liver allograft recipients.
• The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients.
• Vascular oxidative stress in Alzheimer disease.
• Walking in a city neighbourhood, paving the way.
• Work-related ladder fall fractures: identification and diagnosis validation using narrative text.
• You can make a difference.